Takeda Pharmaceuticals North America, Inc. (TPNA) is a new kind of pharmaceutical company. We are dedicated to serving patients by providing innovative products that improve their lives with better healthcare. With a foundation built on the tremendous success of ACTOS® (pioglitazone HCl) as well as a robust, early-stage pipeline, TPNA is poised to realize its vision of becoming a world class pharmaceutical company.
Our unique culture sets us apart. At TPNA, we are committed to patients, our employees and the community. We have an innovative, entrepreneurial spirit combined with the rich history of our 220-year-old parent company.
Headquartered in Lincolnshire, Illinois, a northern suburb of Chicago, TPNA is a wholly owned U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. With more than five years of service in the U.S., we have grown rapidly and each step of that growth remains true to the company’s integrity, heritage and people.
Takeda Pharmaceuticals North America, Inc. has a solid foundation built on successful products, principles, people and research. The company culture is one that supports a unique work environment and encourages employees to focus on collaboration, relationships and personal development.
We are also intensely focused on growth. The company has grown from three employees to more than 2,100 in just over five years, and we know that without a high level of respect and support for each individual, we could not have recruited and maintained that amount of talent.
We hire experts from diverse fields who are aligned with our company values and possess unique skills that will contribute to the development of our expanding pipeline, R&D capabilities and commercial opportunities.
We are working each day to improve the lives of our patients, our community and employees, and believe we offer a combination of entrepreneurial spirit and proven performance that makes a difference in people’s lives.
